Transcriptomic characterization of the long-term dihydrotestosterone effects in adipose tissue

Obesity

Volumn 15, Issue 5, 2007, Pages 1107-1132

  Bolduc, Carl ^a   Yoshioka, Mayumi ^a   St Amand, Jonny ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Gene expression; Lipid metabolism; Molecular genetics; Sex hormones

Indexed keywords

ANDROSTANOLONE; FRUCTOSE BISPHOSPHATE ALDOLASE; MALATE DEHYDROGENASE; PYRUVATE KINASE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GLYCOLYSIS; MALE; MOUSE; ORCHIECTOMY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; DIHYDROTESTOSTERONE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION REGULATION; GLYCOLYSIS; MALATE DEHYDROGENASE; MALE; MICE; MICE, INBRED C57BL; ORCHIECTOMY; PYRUVATE KINASE; TRANSCRIPTION, GENETIC;

MUS;

EID: 34250623941     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.623     Document Type: Article

References (55)

1. Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Mean Circ Physiol. 2005;288:2031-41.
2. Sheehan MT, Jensen MD. Metabolic complications of obesity: pathophysiologic considerations. Med Clin North Am. 2000:84:363-85.
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
4. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev. 2004;5:197-216.
5. Bélanger C, Luu-The V, Dupont P, Tchernof A. Adipose tissue intracrinology: potential importance of local androgen/ estrogen metabolism in the regulation of adiposity. Horm Metab Res. 2002;34:737-45.
6. Tchernof A, Despres JP, Belanger A, et al. Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism. 1995:44:513-9.
7. Seidell JC, Björntorp P, Sjöström L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism. 1990;39:897-901.
8. Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003;51:101-5.
9. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 1983;57:304-10.
10. Bolduc C, Larose M, Yoshioka M, et al. Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. J Mol Endocrinol. 2004;33:429-44.
11. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science. 1995;270:484-7.
12. St.-Amand J, Okamura K, Matsumoto K, Shimizu S, Sogawa Y. Characterization of control and immobilized skeletal muscle: an overview from genetic engineering. FASEB J. 2001;15:684-92.
13. Luu-The V, Paquet N, Calvo E, Cumps J. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques. 2005;38:287-93.
14. Dinel S, Bolduc C, Belleau P, et al. Reproducibility, bioinformatic analysis and power of the SAGE method to evaluate changes in transcriptome. Nucleic Acids Res. 2005;33:e26.
15. Adams M, Kerlavage A, Fleischmann R, et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature. 1995;377:3-174.
16. Lash A, Tolstoshev C, Wagner L, et al. SAGEmap: a public gene expression resource. Genome Res. 2000;10:1051-60.
17. Marin P, Krotkiewski M, Björntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med. 1992;1:329-36.
18. Marin P. Testosterone and regional fat distribution. Obes Res. 1995;3(Suppl 4):609-12S.
19. Soni KG, Lehner R, Metalnikov P, et al. Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase. J Biol Chem. 2004; 279:40683-9.
20. Osuga J, Ishibashi S, Oka T, et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA. 2000:97:787-92.
21. Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans. 2003;31: 1120-4.
22. Gogos JA, Morgan M, Luine V, et al. Catechol-O-methyltransferase- deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA. 1998;95:9991-6.
23. Oh W, Abu-Elheiga L, Kordari P, et al. Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. Proc Natl Acad Sci USA. 2005;102:1384-9.
24. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 2001 ;291: 2613-6.
25. Jogl G, Tong L. Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport. Cell. 2003;112:113-22.
26. Ramsay RR, Gandour RD, van der Leij FR. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta. 2001;1546:21-43.
27. Wood PA. Defects in mitochondrial beta-oxidation of fatty acids. Curr Opin Lipidol. 1999;10:107-12.
28. Wanders RJA. Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab. 2004;83:16-27.
29. Voet D, Voet JG. Biochemistry. New York, NY: John Wiley & Sons; 1995.
30. Beigneux AP, Kosinski C, Gavino B, Horton JD, Skarnes WC, Young SG. ATP-citrate lyase deficiency in the mouse. J Biol Chem. 2004;279:9557-64.
31. Bagchi S, Wise LS, Brown ML, Bregman D, Sul HS, Rubin CS. Structure and expression of murine malic enzyme mRNA: differentiation-dependent accumulation of two forms of malic enzyme mRNA in 3T3-L1 cells. J Biol Chem. 1987;262: 1558-65.
32. Jain M, Cui L, Brenner DA, et al. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation. 2004;109: 898-903.
33. Xu ZP, Wawrousek EF, Piatigorsky J. Transketolase haploinsufficiency reduces adipose tissue and female fertility in mice. Mol Cell Biol. 2002;22:6142-7.
34. Schmid B, Rippmann JF, Tadayyon M, Hamilton BS. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochem Biophys Res Commun. 2005;328:1073-82.
35. Magre J, Delepine M, Van Maldergem L, et al. Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes. 2003;52:1573-8.
36. Liang L, Zhao M, Xu Z, Yokoyama KK, Li T. Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family. Biochem J. 2003;370:195-203.
37. Chen G, Cizeau J, Vande Velde C, et al. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J Biol Chem. 1999:274:7-10.
38. Kiyokawa H, Busquets X, Powell CT, Ngo L, Rifkind RA, Marks PA. Cloning of a D-type cyclin from murine erythroleukemia cells. Proc Natl Acad Sci USA. 1992:89:2444-7.
39. Bai F, Pei XH, Godfrey VL, Xiong Y. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol Cell Biol. 2003:23:1269-77.
40. Tzen CY, Huang YW. Cloning of murine early quiescence-1 gene: the murine counterpart of dermatopontin gene can induce and be induced by cell quiescence. Exp Cell Res. 2004;294:30-8.
41. Pradeep PK, Li X, Peegel H, Menon KMJ. Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase. Endocrinology. 2002;143:2930-5.
42. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89:2563-8.
43. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439-51.
44. Ueda Y, Royer L, Gong E, et al. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem. 1999;274:7165-71.
45. Ueda Y, Gong E, Royer L, Cooper PN, Francone OL, Rubin EM. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem. 2000;275:20368-73.
46. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 1999;274:19055-62.
47. Soga T, Kamohara M, Takasaki J, et al. Molecular identification of nicotinic acid receptor. Biochem Biophys Res Commun. 2003;303:364-9.
48. Bradshaw AD, Graves DC, Motamed K, Sage EH. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci USA. 2003;100:6045-50.
49. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature. 1995;377:151-5.
50. Gooren L. Hormone treatment of the adult transsexual patient. Horm Res. 2005;64(Suppl 2):31-6.
51. Lapointe J, Fournler A, Richard V, Labrie C. Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells. Endocrinology. 1999;140:416-21.
52. Pelletier G, Luu-The V, Li S, Labrie F. Localization of type 8 17beta-hydroxysteroid dehydrogenase mRNA in mouse tissues as studied by in situ hybridization. J Histochem Cytochem. 2005;53:1257-71.
53. Song WC. Biochemistry and reproductive endocrinology of estrogen sulfotransferase. Ann NY Acad Sci. 2001:948:43-50.
54. Anderson LA, McTernan PG, Harte AL, Barnett AH, Kumar S. The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes Obes Metab. 2002:4:209-13.
55. Webb O, Laskarzewski P, Glueck C. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism. 1984;33: 971-5.